LAWRENCE, Mass., Sept. 1 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, and Robert Brown, Chief Financial Officer, will be presenting at the UBS Global Life Sciences Conference on Tuesday, September 22, 2009 at the Grand Hyatt, Grand Central in New York City.
NxStage's investor presentation is scheduled for Tuesday, September 22nd at 4:00 p.m. (EST). To listen to the audio webcast of the presentation during the event, please visit: http://www.nxstage.com and click on 'Investor Information'.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at http://www.nxstage.com.
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. E
|SOURCE NxStage Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved